Literature DB >> 8845168

Mutations in dominant human myotonia congenita drastically alter the voltage dependence of the CIC-1 chloride channel.

M Pusch1, K Steinmeyer, M C Koch, T J Jentsch.   

Abstract

Autosomal dominant myotonia congenita (Thomsen's disease) is caused by mutations in the muscle chloride channel CIC-1. Several point mutations found in affected families (I29OM, R317Q, P480L, and Q552R) dramatically shift gating to positive voltages in mutant/WT heterooligomeric channels, and when measurable, even more so in mutant homooligomers. These channels can no longer contribute to the repolarization of action potentials, fully explaining why they cause dominant myotonia. Most replacements of the isoleucine at position 290 shift gating toward positive voltages. Mutant/WT heterooligomers can be partially activated by repetitive depolarizations, suggesting a role in shortening myotonic runs. Remarkably, a human mutation affecting an adjacent residue (E291K) is fully recessive. Large shifts in the voltage dependence of gating may be common to many mutations in dominant myotonia congenita.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8845168     DOI: 10.1016/0896-6273(95)90023-3

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  55 in total

Review 1.  Chloride channel diseases resulting from impaired transepithelial transport or vesicular function.

Authors:  Thomas J Jentsch; Tanja Maritzen; Anselm A Zdebik
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

Review 2.  Muscle channelopathies and critical points in functional and genetic studies.

Authors:  Karin Jurkat-Rott; Frank Lehmann-Horn
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

3.  Functional complementation of truncated human skeletal-muscle chloride channel (hClC-1) using carboxyl tail fragments.

Authors:  Weiping Wu; Grigori Y Rychkov; Bernard P Hughes; Allan H Bretag
Journal:  Biochem J       Date:  2006-04-01       Impact factor: 3.857

Review 4.  Diagnostics and therapy of muscle channelopathies--Guidelines of the Ulm Muscle Centre.

Authors:  F Lehmann-Horn; K Jurkat-Rott; R Rüdel
Journal:  Acta Myol       Date:  2008-12

5.  Statins and fibrate target ClC-1 - from side effects to CLC pharmacology.

Authors:  Anselm A Zdebik
Journal:  Br J Pharmacol       Date:  2009-04       Impact factor: 8.739

6.  Molecular basis for decreased muscle chloride conductance in the myotonic goat.

Authors:  C L Beck; C Fahlke; A L George
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

7.  Anion- and proton-dependent gating of ClC-4 anion/proton transporter under uncoupling conditions.

Authors:  Gökce Orhan; Christoph Fahlke; Alexi K Alekov
Journal:  Biophys J       Date:  2011-03-02       Impact factor: 4.033

8.  Recessive congenital myotonia resulting from maternal isodisomy of chromosome 7: a case report.

Authors:  Cristina Bulli; Pier Antonio Battistella; Marta Bordignon; Placido Bramanti; Giuseppe Novelli; Federica Sangiuolo
Journal:  Cases J       Date:  2009-04-29

9.  Heteromultimeric CLC chloride channels with novel properties.

Authors:  C Lorenz; M Pusch; T J Jentsch
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

10.  Concentration and pH dependence of skeletal muscle chloride channel ClC-1.

Authors:  G Y Rychkov; M Pusch; D S Astill; M L Roberts; T J Jentsch; A H Bretag
Journal:  J Physiol       Date:  1996-12-01       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.